Medivir   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Stockholm Sweden (1998)

Organization Overview

First Clinical Trial
1999
NCT00736437
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Medivir